MicroLine
12.29.20
Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombiSource: Eyenovia
12.16.20
Eyenovia Announces First Patients Enrolled in Phase 3 Study of MicroLine for PresbyopiaSource: Eyenovia
12.03.20
FDA Approves Eyenovia’s IND Application for MicroLine for Presbyopia, Allowing for Phase 3 TrialsSource: Eyenovia